CMTM6 and neoplasm: Indeed, our results demonstrate that the co-expression of CMTM6 or CMTM4 with PD-L1 on the membrane of tumor cells is critical for immunotherapeutic response and the pathological patterns of their expression may provide detailed information to conduct personalized immunotherapy.